热门资讯> 正文
DaVita、伯克希尔哈撒韦墨水股份购买协议
2024-05-02 21:52
- 德维特(DVA) 0
- 伯克希尔B(BRK.B) 0
- 伯克希尔(BRK.A) 0
- Dialysis provider DaVita (NYSE:DVA) has reached a share repurchase agreement with Warren Buffett’s business conglomerate Berkshire Hathaway (BRK.A.), the company’s largest stockholder.
- Per the terms, the Omaha, Nebraska-based investment giant will sell any shares it owns more than its 45.0% stake in DaVita (DVA) every quarter, the company announced in a regulatory filing late Wednesday.
- The company is expected to buy shares on a volume-weighted average per-share basis, calculated using the prices applicable to the stocks it repurchased from public investors over that period.
- The share repurchases are scheduled to take place two business days before the company’s annual or quarterly earnings calls. However, if Berkshire Hathaway’s (NYSE:BRK.A) stake in DaVita (DVA) exceeds 49.5%, immediate share repurchases will be allowed.
More on DaVita
- DaVita Stock Is A Hold As It Expands In Latin America
- DaVita Inc. (DVA) Q4 2023 Earnings Call Transcript
- DaVita Q1 2024 Earnings Preview
- Fresenius sells dialysis centers in four South American countries to DaVita
- Seeking Alpha’s Quant Rating on DaVita
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
